401 related items for PubMed ID: 31927590
1. Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis.
Messina V, Karlsson L, Hirvikoski T, Nordenström A, Lajic S.
J Clin Endocrinol Metab; 2020 Mar 01; 105(3):e683-91. PubMed ID: 31927590
[Abstract] [Full Text] [Related]
2. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S.
J Clin Endocrinol Metab; 2007 Feb 01; 92(2):542-8. PubMed ID: 17148562
[Abstract] [Full Text] [Related]
3. Cognitive and social function in girls with congenital adrenal hyperplasia -- influence of prenatally administered dexamethasone.
Maryniak A, Ginalska-Malinowska M, Bielawska A, Ondruch A.
Child Neuropsychol; 2014 Feb 01; 20(1):60-70. PubMed ID: 23186079
[Abstract] [Full Text] [Related]
4. Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia.
Karlsson L, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.
Clin Endocrinol (Oxf); 2017 Dec 01; 87(6):651-659. PubMed ID: 28771762
[Abstract] [Full Text] [Related]
5. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Meyer-Bahlburg HF, Dolezal C, Haggerty R, Silverman M, New MI.
Eur J Endocrinol; 2012 Jul 01; 167(1):103-10. PubMed ID: 22549088
[Abstract] [Full Text] [Related]
6. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.
Wallensteen L, Zimmermann M, Thomsen Sandberg M, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.
J Clin Endocrinol Metab; 2016 Oct 01; 101(10):3838-3846. PubMed ID: 27482827
[Abstract] [Full Text] [Related]
7. Good overall behavioural adjustment in children and adolescents with classic congenital adrenal hyperplasia.
Messina V, Hirvikoski T, Karlsson L, Vissani S, Wallensteen L, Ortolano R, Balsamo A, Nordenström A, Lajic S.
Endocrine; 2020 May 01; 68(2):427-437. PubMed ID: 32152914
[Abstract] [Full Text] [Related]
8. Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome.
Karlsson L, Nordenström A, Hirvikoski T, Lajic S.
Psychoneuroendocrinology; 2018 May 01; 91():68-74. PubMed ID: 29529521
[Abstract] [Full Text] [Related]
9. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.
Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI.
J Clin Endocrinol Metab; 2004 Feb 01; 89(2):610-4. PubMed ID: 14764770
[Abstract] [Full Text] [Related]
10. Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance.
Collaer ML, Hindmarsh PC, Pasterski V, Fane BA, Hines M.
Psychoneuroendocrinology; 2016 Feb 01; 64():164-73. PubMed ID: 26677764
[Abstract] [Full Text] [Related]
11. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.
Wallensteen L, Karlsson L, Messina V, Gezelius A, Sandberg MT, Nordenström A, Hirvikoski T, Lajic S.
Horm Behav; 2018 Feb 01; 98():219-224. PubMed ID: 29410007
[Abstract] [Full Text] [Related]
12. RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.
Wallensteen L, Zimmermann M, Sandberg MT, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.
Horm Behav; 2016 Sep 01; 85():5-11. PubMed ID: 27373757
[Abstract] [Full Text] [Related]
13. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
Dörr HG, Sippell WG.
J Clin Endocrinol Metab; 1993 Jan 01; 76(1):117-20. PubMed ID: 8421074
[Abstract] [Full Text] [Related]
14. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 01; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
15. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Jan 01; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
16. Cognitive functions in children with congenital adrenal hyperplasia.
Amr NH, Baioumi AY, Serour MN, Khalifa A, Shaker NM.
Arch Endocrinol Metab; 2019 Jan 01; 63(2):113-120. PubMed ID: 31038592
[Abstract] [Full Text] [Related]
17. First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults.
Van't Westeinde A, Zimmermann M, Messina V, Karlsson L, Padilla N, Lajic S.
J Clin Endocrinol Metab; 2020 Nov 01; 105(11):e4074-82. PubMed ID: 32869847
[Abstract] [Full Text] [Related]
18. General intelligence and cognitive profile in women with congenital adrenal hyperplasia (CAH).
Helleday J, Bartfai A, Ritzén EM, Forsman M.
Psychoneuroendocrinology; 1994 Nov 01; 19(4):343-56. PubMed ID: 8047639
[Abstract] [Full Text] [Related]
19. Cognitive function in children with classic congenital adrenal hyperplasia.
Hamed SA, Metwalley KA, Farghaly HS.
Eur J Pediatr; 2018 Nov 01; 177(11):1633-1640. PubMed ID: 30088136
[Abstract] [Full Text] [Related]
20. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.
JAMA Pediatr; 2014 Jun 01; 168(6):567-74. PubMed ID: 24733564
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
